
  Mrv0541 02231217082D          

 10 10  0  0  1  0            999 V2000
   -0.1467    3.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1467    2.3518    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
   -0.8612    1.9393    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5678    1.9393    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2822    2.3518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5678    1.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2352    0.6294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9803   -0.1553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1553   -0.1553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0997    0.6294    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  6  0  0  0
  2  4  1  0  0  0  0
  4  5  1  1  0  0  0
  4  6  1  0  0  0  0
  6  7  2  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  9 10  1  0  0  0  0
  6 10  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB03724

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol

> <CHEMICAL_FORMULA>
C6H10N2OS

> <MOLECULAR_WEIGHT>
158.221

> <EXACT_MASS>
158.051383642

> <IUPAC_NAME>
(1R,2R)-1-amino-1-(1,3-thiazol-2-yl)propan-2-ol

> <IUPAC_TRADITIONAL_NAME>
(1R,2R)-1-amino-1-(1,3-thiazol-2-yl)propan-2-ol

> <INCHI_IDENTIFIER>
InChI=1S/C6H10N2OS/c1-4(9)5(7)6-8-2-3-10-6/h2-5,9H,7H2,1H3/t4-,5-/m1/s1

> <INCHI_KEY>
InChIKey=QWDNYLFSFTUIKH-RFZPGFLSSA-N

> <SMILES>
C[C@@H](O)[C@@H](N)C1=NC=CS1

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_ACIDIC_PKA>
14.54

> <JCHEM_BASIC_PKA>
7.67

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <ALOGPS_LOGP>
-0.28

> <JCHEM_LOGP>
-0.23

> <ALOGPS_LOGS>
-1.4

> <JCHEM_POLARIZABILITY>
15.97

> <JCHEM_POLAR_SURFACE_AREA>
59.14

> <JCHEM_REFRACTIVITY>
39.52

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <ALOGPS_SOLUBILITY>
5.67e+00 g/l __ 

$$$$
